Mirae Asset Global Investments’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$145M Buy
299,405
+103,136
+53% +$27.4M 0.21% 64
2026
Q1
$21.5M Sell
196,269
-28,930
-13% -$4.12M 0.06% 255
2025
Q4
$37.5M Buy
225,199
+28,639
+15% +$4.79M 0.1% 160
2025
Q3
$38.5M Buy
196,560
+195,379
+16,544% +$32.1M 0.12% 139
2025
Q2
$107K Buy
1,181
+66
+6% +$5.21K ﹤0.01% 1128
2025
Q1
$67.8K Sell
1,115
-7
-0.6% -$648 ﹤0.01% 1185
2024
Q4
$159K Buy
+1,122
New +$105K ﹤0.01% 1082

Other funds holding ALAB

Mirae Asset Global Investments's ALAB Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Astera Labs (ALAB) stake by 53% in Q2 2026, buying an estimated $27.4M and bringing the position to 299,405 shares worth $145M. The position accounts for 0.21% of the portfolio, ranked #64.

Mirae Asset Global Investments first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Mirae Asset Global Investments held 299,405 shares of Astera Labs worth $145M as of Q2 2026.
  • Mirae Asset Global Investments bought 103,136 Astera Labs shares in Q2 2026, an estimated $27.4M.
  • Astera Labs made up 0.21% of Mirae Asset Global Investments's portfolio in Q2 2026, its #64 holding.
  • Mirae Asset Global Investments first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.